Clinical Trials Related to Hematological Malignancies

Related studies linked through entity extraction aliases.

Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality

Status: NOT_YET_RECRUITING
Phase: N/A

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Status: NOT_YET_RECRUITING
Phase: PHASE2

M-2018-334 in Hematological Malignancies

Status: NOT_YET_RECRUITING
Phase: NA

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

Status: RECRUITING
Phase: PHASE1

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

Study of AZD9829 in CD123+ Hematological Malignancies

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Status: RECRUITING
Phase: NA

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Status: UNKNOWN
Phase: N/A

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Status: RECRUITING
Phase: PHASE1/PHASE2

The Study of ICP-248 in Patients With Mature B-cell Malignancies

Status: RECRUITING
Phase: PHASE1

APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU

Status: RECRUITING
Phase: NA

CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies

Status: COMPLETED
Phase: PHASE2

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies

Status: TERMINATED
Phase: PHASE1

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology

Status: RECRUITING
Phase: NA

Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

Status: COMPLETED
Phase: PHASE3

Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation

Status: COMPLETED
Phase: N/A

A Study of TQB3820 in Patients With Hematological Malignancies

Status: UNKNOWN
Phase: PHASE1

A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Status: RECRUITING
Phase: PHASE1/PHASE2